Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine versus fentanyl for preserving spontaneous respiration during general anesthesia in percutaneous kyphoplasty
ChiCTR2600133095Phase 4Not yet recruiting
- Sponsor
- Lishui City Central Hospital
- Start
- Sep 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine, fentanyl and propofol in compression fracture (VCF) and fragility fracture (2 arms), sponsored by Lishui City Central Hospital. Primary endpoint: Respiratory depression rate. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
oliceridinefentanylpropofol
03
Conditions
compression fracture (VCF)fragility fracture
Beyond the preview
Go deeper on ChiCTR2600133095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133095.